AIM ImmunoTech Inc. - 8-K Filing
AIM ImmunoTech Inc. entered into a securities purchase agreement with institutional investors on May 20, 2026, to issue and sell 7,519,351 shares of common stock at $0.325 per share in a registered direct offering for gross proceeds of approximately $2.4 million before expenses. Concurrently, the company issued warrants to purchase up to 15,038,702 shares with an exercise price of $0.325 per share, which could generate additional gross proceeds of about $4.9 million if exercised in full for cash after stockholder approval. The placement agent received a fee and warrants to purchase 6% (or 451,... (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $AIM